These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 35941638)
21. Development of a prognostic signature for esophageal cancer based on nine immune related genes. Zhang Z; Chen C; Fang Y; Li S; Wang X; Sun L; Zhou G; Ye J BMC Cancer; 2021 Feb; 21(1):113. PubMed ID: 33541291 [TBL] [Abstract][Full Text] [Related]
22. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma. Qi X; Qi C; Qin B; Kang X; Hu Y; Han W Front Oncol; 2020; 10():541330. PubMed ID: 33072571 [No Abstract] [Full Text] [Related]
23. Identification of an immune-related gene signature as a prognostic target and the immune microenvironment for adrenocortical carcinoma. Xu C; Qin C; Jian J; Peng Y; Wang X; Chen X; Wu D; Song Y Immun Inflamm Dis; 2022 Sep; 10(9):e680. PubMed ID: 36039643 [TBL] [Abstract][Full Text] [Related]
24. A Risk Model Based on Immune-Related Genes Predicts Prognosis and Characterizes the Immune Landscape in Esophageal Cancer. Xie Y; Fu R; Xiao Z; Li G Pathol Oncol Res; 2022; 28():1610030. PubMed ID: 35356506 [TBL] [Abstract][Full Text] [Related]
25. Development and Validation of a Machine Learning Prognostic Model of m5C Related immune Genes in Lung Adenocarcinoma. Cao X; Ji Y; Li J; Liu Z; Chen C Cancer Control; 2024; 31():10732748241237414. PubMed ID: 38537151 [TBL] [Abstract][Full Text] [Related]
26. Prognostic model of 10 immune-related genes and identification of small molecule drugs in bladder urothelial carcinoma (BLCA). Xing Q; Liu S; Jiang S; Li T; Wang Z; Wang Y Transl Androl Urol; 2020 Oct; 9(5):2054-2070. PubMed ID: 33209669 [TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of colorectal cancer. Li W; Jin X; Guo S; Xu F; Su X; Jiang X; Wang G Aging (Albany NY); 2021 Feb; 13(4):5506-5524. PubMed ID: 33536348 [TBL] [Abstract][Full Text] [Related]
28. Eleven inflammation-related genes risk signature model predicts prognosis of patients with breast cancer. Hu H; Yuan S; Fu Y; Li H; Xiao S; Gong Z; Zhong S Transl Cancer Res; 2024 Jul; 13(7):3652-3667. PubMed ID: 39145071 [TBL] [Abstract][Full Text] [Related]
29. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma. Shen R; Liu B; Li X; Yu T; Xu K; Ma J BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781 [TBL] [Abstract][Full Text] [Related]
30. Identification of a five-gene signature with prognostic value in colorectal cancer. Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881 [TBL] [Abstract][Full Text] [Related]
31. Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma. Long J; Zhang S; Zeng X; Ouyang Y; Wang Y; Hu Z; Ye Y; Wu W; Jin F; Zhou S; Zeng Z Front Mol Biosci; 2020; 7():586344. PubMed ID: 33330624 [TBL] [Abstract][Full Text] [Related]
32. Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients. Ke J; Liu XH; Jiang XF; He Z; Xiao J; Zheng B; Chen YF; Cai ZR; Zheng XB; Zou YF; Lan P; Wu XJ; Gao F Eur J Surg Oncol; 2020 Oct; 46(10 Pt B):e62-e70. PubMed ID: 32863096 [TBL] [Abstract][Full Text] [Related]
33. A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients. Ye D; Liu Y; Li G; Sun B; Peng J; Xu Q Front Oncol; 2021; 11():766072. PubMed ID: 34868990 [TBL] [Abstract][Full Text] [Related]
34. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence. Yu S; Chen M; Xu L; Mao E; Sun S Front Immunol; 2023; 14():1175490. PubMed ID: 37090726 [TBL] [Abstract][Full Text] [Related]
35. Risk stratification and prognosis prediction based on inflammation-related gene signature in lung squamous carcinoma. Zhai W; Chen S; Duan F; Wang J; Zhao Z; Lin Y; Rao B; Wang Y; Zheng L; Long H Cancer Med; 2023 Feb; 12(4):4968-4980. PubMed ID: 36056909 [TBL] [Abstract][Full Text] [Related]
36. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma. Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167 [TBL] [Abstract][Full Text] [Related]
37. A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma. Yan Q; Zheng W; Wang B; Ye B; Luo H; Yang X; Zhang P; Wang X BioData Min; 2021 May; 14(1):29. PubMed ID: 33962640 [TBL] [Abstract][Full Text] [Related]
38. Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients. Wang Q; Vattai A; Vilsmaier T; Kaltofen T; Steger A; Mayr D; Mahner S; Jeschke U; Hildegard Heidegger H Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671013 [TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer. Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319 [TBL] [Abstract][Full Text] [Related]
40. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer. Yue Y; Zhang Q; Sun Z Front Immunol; 2021; 12():758040. PubMed ID: 35140706 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]